Literature DB >> 10569735

Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria.

L Huang1, A M Krieg, N Eller, D E Scott.   

Abstract

Th1 immune responses, characterized by production of gamma interferon (IFN-gamma), are associated with protective immunity to viruses and intracellular bacteria. Heat-killed Brucella abortus promotes secretion of Th1-inducing cytokines such as interleukin-12 (IL-12) and IFN-gamma and has been used as a carrier to induce Th1 responses to vaccines. To explore which bacterial constituents could mediate this response and how it is regulated, murine spleen cells were cultured with B. abortus derived DNA, lipopolysaccharide (LPS), or whole killed organisms. Each constituent induced similar, substantial amounts of IL-10. However, only B. abortus and B. abortus DNA induced high levels of IFN-gamma and IL-12. B. abortus and B. abortus DNA-stimulated IL-12 production was maximal by 6 to 18 h, while IL-10 production steadily accumulated over this time period. These kinetics suggested that IL-10 may eventually downmodulate the Th1-like cytokine response to B. abortus and B. abortus DNA, which was confirmed by using neutralizing antibody. In the absence of IL-10, B. abortus LPS induced strong IFN-gamma responses, but IL-12 p70 levels were still undetectable from BALB/c spleen cells. LPS induced IL-12 if the spleen cells were primed with IFN-gamma and IL-10 was neutralized, indicating that LPS can stimulate IL-12 production under the most favorable conditions. Responses to Escherichia coli LPS and DNA mirrored the responses to B. abortus components, suggesting that immune effects observed with these constituents may be generalizable to many microbial species. In vivo experiments demonstrated the same hierarchy of responses for IL-12 production. These findings support the likelihood that microbial components, if used as carriers or adjuvants, can differ substantially in their ability to effect a Th1 response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569735      PMCID: PMC97027          DOI: 10.1128/IAI.67.12.6257-6263.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma.

Authors:  T F Gajewski; J Joyce; F W Fitch
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma).

Authors:  G Trinchieri
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

4.  Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1.

Authors:  T B Oriss; S A McCarthy; B F Morel; M A Campana; P A Morel
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

5.  Contribution of CpG motifs to the immunogenicity of DNA vaccines.

Authors:  D M Klinman; G Yamshchikov; Y Ishigatsubo
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

6.  B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.

Authors:  S Maruo; M Oh-hora; H J Ahn; S Ono; M Wysocka; Y Kaneko; H Yagita; K Okumura; H Kikutani; T Kishimoto; M Kobayashi; T Hamaoka; G Trinchieri; H Fujiwara
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

7.  Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40.

Authors:  R H DeKruyff; R S Gieni; D T Umetsu
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

8.  Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo.

Authors:  M K Gately; D M Carvajal; S E Connaughton; S Gillessen; R R Warrier; K D Kolinsky; V L Wilkinson; C M Dwyer; G F Higgins; F J Podlaski; D A Faherty; P C Familletti; A S Stern; D H Presky
Journal:  Ann N Y Acad Sci       Date:  1996-10-31       Impact factor: 5.691

9.  The cytokines IL-4, IFN-gamma, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro.

Authors:  L M Bradley; K Yoshimoto; S L Swain
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

10.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

View more
  11 in total

1.  Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.

Authors:  Arnaud Machelart; Abir Khadrawi; Aurore Demars; Kevin Willemart; Carl De Trez; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

2.  Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection.

Authors:  P Pasquali; R Adone; L C Gasbarre; C Pistoia; F Ciuchini
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae.

Authors:  Abdul Q Khan; Yi Shen; Zheng-Qi Wu; Thomas A Wynn; Clifford M Snapper
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge.

Authors:  T D Crabtree; L Jin; D P Raymond; S J Pelletier; C W Houlgrave; T G Gleason; T L Pruett; R G Sawyer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1alpha and 1beta following stimulation with heat-inactivated Brucella abortus.

Authors:  M Zaitseva; L R King; J Manischewitz; M Dougan; L Stevan; H Golding; B Golding
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godefroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23.

Authors:  Mario Weinhold; Martin Eisenblätter; Edith Jasny; Michael Fehlings; Antje Finke; Hermine Gayum; Ursula Rüschendorf; Pablo Renner Viveros; Verena Moos; Kristina Allers; Thomas Schneider; Ulrich E Schaible; Ralf R Schumann; Martin E Mielke; Ralf Ignatius
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

8.  MyD88 associated ROS generation is crucial for Lactobacillus induced IL-12 production in macrophage.

Authors:  Shintaro Ichikawa; Mika Miyake; Rei Fujii; Yutaka Konishi
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

9.  Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19.

Authors:  Zahra Kianmehr; Sussan Kaboudanian Ardestani; Hoorieh Soleimanjahi; Fatemeh Fotouhi; Saeed Alamian; Shahin Ahmadian
Journal:  Jundishapur J Microbiol       Date:  2015-11-07       Impact factor: 0.747

Review 10.  The hygiene hypothesis: current perspectives and future therapies.

Authors:  Leah T Stiemsma; Lisa A Reynolds; Stuart E Turvey; B Brett Finlay
Journal:  Immunotargets Ther       Date:  2015-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.